Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Bongarzoni, A."'
Autor:
Giusy Cetani, Mario Boccadoro, Daniele Derudas, Andrea Capra, Delia Rota Scalabrini, Maria Teresa Petrucci, Alessandra Malfitano, Paolo Corradini, Michele Cavo, Roberto Mina, Pellegrino Musto, Massimo Offidani, Velia Bongarzoni, Giuseppe Milone, Francesco Pisani, Chiara Nozzoli, Tommaso Caravita di Toritto, Roberto M. Lemoli, Francesca Bonello, Alessandra Larocca, Stelvio Ballanti, Patrizia Tosi
Publikováno v:
Blood. 136:13-14
Background. High-dose melphalan followed by autologous stem cell transplantation is a standard of care in transplant-eligible newly diagnosed multiple myeloma (NDMM) patients and is also an option at relapse. Therefore, since the minimum number of CD
Autor:
Concetta Conticello, Paola Bertazzoni, Valerio Leotta, Federico Vozella, Angelo Belotti, Guido Montanaro, Monica Galli, Loredana Pettine, Sara Aquino, Adelina Sementa, Ugo Consoli, Velia Bongarzoni, Alessandra Lombardo, Salvatore Palmieri, Annalisa Citro, Alessandro Inzoli, Alessandra Pompa, Elisabetta Antonioli, Valeria Ferla, Agostina Siniscalchi, Laura Paris, Lucia Tognazzi, Diana Giannarelli, Francesca Gaia Rossi, Silvia Mangiacavalli, Gabriele Buda, Alessandra Romano, Alfredo Molteni, Francesca Cavallaro, Daniele Derudas, Iolanda Vincelli, Massimo Gentile, Angela Bonalumi, Sara Pezzatti, Renato Zambello, Luca Baldini, Vittorio Del Fabro, Niccolò Frungillo, Francesca Fioritoni, Magda Marcatti, Federica Elia
Publikováno v:
Blood. 134:5555-5555
Introduction Lenalidomide (Len) and low-dose Dexamethasone (dex) (Rd) in continuous is a new standard of care for elderly newly-diagnosed multiple myeloma (NDMM) patients (pts), as established by FIRST trial (Facon et al, Blood 2018). Methods and res
Autor:
Marco Russano, Angela Rago, Elisabetta Lisi, Alessia Fiorini, Daniele Santini, Francesco Pisani, Olga Venditti, Luca Franceschini, Velia Bongarzoni, Francesco Pantano, Ombretta Annibali, Elisabetta Cerchiara, MArco Mariani, Giuseppe Avvisati, Maria Teresa Petrucci, Stefano Felici
Publikováno v:
Blood. 126:5359-5359
Background: alkaline phosphatase (ALP) is an enzyme localized in different tissues and its levels may increase in diseases with skeletal involvement. Aim: To compare ALP levels in patients with Multiple Myeloma and osteolytic lesions, and in patients
Autor:
Alessandro Gozzetti, Francesca Romana Mauro, Velia Bongarzoni, Mariarita Sciumè, Robin Foà, Francesco Ghio, Patrizia Mondello, Giovanni Del Poeta, Anticoli Borza Paola, Riccardo Boncompagni, Mario Petrini, Nicola Piccirillo, Maria Rosa Lanza Cariccio, Daniele Vincenti, Giovanni D'Arena, Roberta Murru, Agostino Cortelezzi, Vincenzo Pitini, Maria Ilaria Del Principe, Barbara Vannata, Simona Sica, Nadia Cecconi, Luca Laurenti, Stefania Ciolli, F. Autore, Idanna Innocenti, Maria Cantonetti
Publikováno v:
Blood. 124:5655-5655
The front-line therapy for CLL young and fit patients is chemo-immunotherapy with Fludarabine-Cyclophosphamide and Rituximab (FCR). However, around three quarter of the patients with a newly diagnosed CLL are 65 years or older, with approximately 42%
Autor:
Anna Chierichini, Francesca Monardo, Barbara Anaclerico, Paola Anticoli Borza, Velia Bongarzoni, Domenico Campagna, Michele Cedrone, Susanna Fenu, Marianna Norata, Francesca Paoloni, Benedetto Ronci, Luciana Annino
Publikováno v:
Blood. 122:5589-5589
Background Clinical diagnosis of IFI is difficult ,due to lack of sensitive and specific diagnostic tools. An assessment of trends concerning the prevalence of IFI is a challenge and postmortem data may be useful to monitor the local epidemiology ,th
Autor:
Maria Grazia Lipari, Alberto Mussetti, Sergio Storti, Alessandro Andriani, Giuseppe Pietrantuono, Roberto Guariglia, Velia Bongarzoni, Catello Califano, Stefania Tamiazzo, Vincenzo Ludovico Fraticelli, Andrea Nozza, Daniele Derudas, Vittorio Montefusco, Alberto Fragasso, Cristiana Gasbarrino, Giuseppe Mele, Stelvio Ballanti, Giuliana Farina, Maria Carmen Martorelli, Giovanni D'Arena, Antonio Palumbo, Luca Baldini, Maria Pia Petrilli, Donatella Vincelli, Giovanna Mansueto, Antonietta Falcone, Francesca Patriarca, Oreste Villani, Lucio Catalano, Renato Zambello, Emanuela Madonna, Pellegrino Musto
Publikováno v:
Blood. 120:2971-2971
Abstract 2971 Introduction: Bendamustine is a bifunctional alkylating agent approved for the treatment of several lymphoproliferative disorders. Studies have evidenced its efficacy in multiple myeloma (MM), but data so far available in this setting a
Autor:
Piero Iacovino, Rosa Greco, Velia Bongarzoni, Fulvio Pauselli, Benedetto Ronci, Francesca Monardo, Luciana Annino, Barbara Anaclerico, Giuseppe Avvisati
Publikováno v:
Blood. 114:4939-4939
Abstract 4939 Background Single or tandem Autologous Stem Cell Transplantation (ASCT) has been considered standard approach in adult ( Patients and Methods Between October 2002 and July 2008, at Hematology Unit of S. Giovanni Hospital, 24 pts (median
Autor:
Anna Levi, U Coppetelli, Francesco Pisani, Velia Bongarzoni, Alessandro Andriani, Giuseppe Avvisati, Alessandro Agrillo, Maria Teresa Petrucci, Nicoletta Villivà, Agostina Siniscalchi, Marianna De Muro, Domenico Gaglioti, Marco Montanaro, Tommaso Caravita
Publikováno v:
Blood. 114:2818-2818
Abstract 2818 Poster Board II-794 INTRODUCTION: Bisphosphonate (BSFs) are an effective drug which have been mainly used in oncology for the treatment of solid tumour with bone metastasis, as well as for haematologic disease such as multiple myeloma (
Autor:
Giuseppe Avvisati, Alessandro Agrillo, Anna Levi, Alessandro Andriani, Velia Bongarzoni, Nicoletta Villivà, Marianna De Muro, Agostina Siniscalchi, Domenico Gaglioti, Tommaso Caravita, Francesco Pisani, U Coppetelli, Marco Montanaro, Maria Teresa Petrucci
Publikováno v:
Blood. 112:2705-2705
INTRODUCTION: Bisphosphonates (Bsf) are a recognized and effective class of drugs used intravenously to treat cancer-related conditions, such as multiple myeloma (MM) and others solid tumours for the prevention of pathologic fractures, and in oral fo
Autor:
Paola Anticoli Borza, Velia Bongarzoni, Benedetto Ronci, Barbara Anaclerico, Maria Concetta Petti, Michele Cedrone, Mariangela Vittori, Susanna Fenu, Luciana Annino, Maria Cantonetti, Anna Chierichini
Publikováno v:
Blood. 112:4954-4954
Background. Relapsed/refractory high grade NHL is a very aggressive pathology characterised by a poor prognosis. High dose therapy followed by peripheral blood stem cell (PBSC) rescue is to date the gold standard therapy. The results of high dose the